fashion -WSS

fashion

author：leisure time 2025-09-28 23:48:30 - browse：9599

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： With trial win, GSK could get blood cancer drug back on market

WSS

NIH documents show early flaws of $1.6 billion long Covid program

FDA's Pazdur wants cancer trials to range beyond China alone

iTeos Therapeutics debuts first data on TIGIT

Ionis drug prevents swelling attacks due to hereditary angioedema

Prosthetic arm enables patients to feel the objects they grip

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

explore

fashion

knowledge

At least 13 dead in Texas as scorching temps continue

NIH documents show early flaws of $1.6 billion long Covid program

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AI used to predict Covid

23andMe had bad news about my health. I wish a person had delivered it

How to increase colonoscopy rates? Looks like an AI can help

Cancer drug shortages should be causing more outrage

Focused ultrasound for uterine fibroids: an uphill battle

Dobbs anniversary: the lost opportunity of abortion as health care

Report: NIH

Wikipedia

Ionis drug prevents swelling attacks due to hereditary angioedema

Average age of first period drops to 11.9 years, study shows

Do more moles mean more problems? Not so, says new study

Intellia reports positive results for its CRISPR

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Heat waves linked to early deliveries, preterm births in new study

hotspot

hotspot

leisure time

hotspot